These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14464002)
1. Observations on the complement-fixing antibody response in human poliomyelitis. Influence of age and vaccination status. LENNETTE EH; MAGOFFIN RL; SCHMIDT NJ J Immunol; 1962 Sep; 89():358-66. PubMed ID: 14464002 [No Abstract] [Full Text] [Related]
2. Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies. FLACK A; HUMMELER K; HUNT AD; JERVIS GA; KOPROWSKI H; NORTON TW; STOKES J J Am Med Assoc; 1956 Dec; 162(14):1281-8. PubMed ID: 13366742 [No Abstract] [Full Text] [Related]
3. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation. SALK JE; BAZELEY PL; BENNETT BL; KRECH U; LEWIS LJ; WARD EN; YOUNGNER JS Am J Public Health Nations Health; 1954 Aug; 44(8):994-1009. PubMed ID: 13180761 [No Abstract] [Full Text] [Related]
4. [Behavior of complement-fixing antibodies durign anti-poliomyelitis vaccination according to the Salk method]. CASSANO A; NUZZOLO L; RAVETTA M; MARINONI G; RIZZA O; GIORDANO G Boll Soc Ital Biol Sper; 1960 Feb; 36():185-8. PubMed ID: 13808204 [No Abstract] [Full Text] [Related]
5. [Complement fixing antibodies after vaccination with inactivated polio virus]. LENNARTZ H; HERTENSTEIN C; CRUESEMANN R Klin Wochenschr; 1959 Dec; 37():1261-2. PubMed ID: 14415702 [No Abstract] [Full Text] [Related]
6. Poliovirus antibody response after various vaccination schedules and at different ages. MACLEOD DR; ARMSTRONG CW; MOSS GW; POTTER FC; WILSON RJ Can Med Assoc J; 1959 Sep; 81(6):443-9. PubMed ID: 14419587 [No Abstract] [Full Text] [Related]
8. The antibody response to poliomyelitis vaccine in school-children at the time of initial vaccination and one year later. ARMSTRONG CW; MOSS GW; POTTER FC Can J Public Health; 1957 Mar; 48(3):96-100. PubMed ID: 13413743 [No Abstract] [Full Text] [Related]
9. [On the complement-fixing antibody titers of poliomyelitis and patients who are suspected of having poliomyelitis viruses infection-The movement of Y and H-antibody]. KANEKO I Paediatr Jpn; 1962 Feb; 66():110-8. PubMed ID: 14453584 [No Abstract] [Full Text] [Related]
10. [Examinations on poliomyelitis antibodies in the population and the practical significance of antibody determination in poliomyelitis vaccination]. KELLER W Monatsschr Kinderheilkd (1902); 1956 Mar; 104(3):135-6. PubMed ID: 13321825 [No Abstract] [Full Text] [Related]
11. [Virological research after oral poliomyelitis vaccination (Sabin). 1. Research on viral excretion, antibody formation and frequency of contact infections]. HAAS R; DOSTAL V; LINDENMANN J; MAASS G; THOMSSEN R Dtsch Med Wochenschr; 1961 Dec; 86():2413-21. PubMed ID: 13903355 [No Abstract] [Full Text] [Related]
12. [Virus excretion and antibody formation after double oral poliomyelitis vaccination (Cox triple vaccine and Sabin vaccine)]. JUST M; BUERGIN-WOLFF A Ann Paediatr; 1962; 199():245-9. PubMed ID: 14452877 [No Abstract] [Full Text] [Related]
13. A method for the rapid determination of immunogenic potency of poliomyelitis vaccines by single vaccination of white rats. GHENDON IZ; MARCHENKO AT Acta Virol; 1959 Oct; 3():250-2. PubMed ID: 13849934 [No Abstract] [Full Text] [Related]
14. [On the question of antibody formation in the newborn after oral polimyelitis vaccination]. RENTSCH M; ROSSIE ; von MURALT G; WIESMANN E Helv Paediatr Acta; 1961 Dec; 16():821-35. PubMed ID: 14491511 [No Abstract] [Full Text] [Related]
15. [Antibody response to a vaccination against polio virus during treatment with isonicotinic acid hydrazide]. PITZURRA M; CUSMA N; BISCATTI O; DONATI M Boll Soc Ital Biol Sper; 1962 Feb; 38():130-2. PubMed ID: 14487009 [No Abstract] [Full Text] [Related]
16. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization]. MORRONE G; NUNZIATA B Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315 [No Abstract] [Full Text] [Related]
17. Immunogenicity, in children, of ultraviolet-treated poliomyelitis vaccine. WOLF AM; SHAUGHNESSY HJ; CHURCH RE; MILZER A; JANOTA M; OPPENHEIMER F; MORRISSEY RA; NAFTULIN H; CHAPMAN JW; LEVINSON SO J Am Med Assoc; 1956 Jun; 161(9):775-81. PubMed ID: 13319005 [No Abstract] [Full Text] [Related]
18. [Behavior of complement-fixing antibodies against poliomyelitis in an infantile community of Milan]. Braga A Ann Sclavo; 1971; 13(3):343-52. PubMed ID: 5153361 [No Abstract] [Full Text] [Related]
19. [Complement fixation test after vaccination with live poliomyelitis vaccine (Sabin strains)]. Terraillon J; Sohier R; Brigaud M; Gramusset J; Laconche N; Blondeau G; Feroldi C Ann Inst Pasteur (Paris); 1967 Jan; 112(1):54-64. PubMed ID: 6031425 [No Abstract] [Full Text] [Related]
20. Poliomyelitis complement-fixing antibodies and their demonstration. BLACK FL Ann N Y Acad Sci; 1955 Sep; 61(4):781-6; discussion, 786-9. PubMed ID: 13340584 [No Abstract] [Full Text] [Related] [Next] [New Search]